Fulcrum Therapeutics, Inc.
FULC • NASDAQ • Stock Fundamentals
Fulcrum Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Alexander C. Sapir, with a market cap of $236.5M.
Market Cap$236.5M
Employees89.0
CEOAlexander C. Sapir
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsApr 27, 2026 · 1 month 18 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Fulcrum Therapeutics, Inc. FAQ
Common questions about Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc. (FULC) has a market capitalization of $236.5M and trades on NASDAQ.
Fulcrum Therapeutics, Inc. has approximately 89 employees.